glutamine glutathione depletion Frontiers Frontiers | Preclinical investigations of
Frontiers Preclinical investigations of the efficacy of the glutaminase inhibitor CB 839 alone and in combinations in chronic lymphocytic leukemia Targeting glutamine metabolism as a therapeutic strategy for cancer PMC Envirotune CAR T: a hypoxia responsive and glutamine enhanced CAR T cell therapy for overcoming tumor microenvironment mediated suppression Journal for ImmunoTherapy of Cancer Glutamine metabolism in cancer therapy
Pay in 4 interest-free payments of $5.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



